Real-world evidence of dupilumab efficacy and risk of adverse events: a systematic review and meta-analysis

AS Halling, N Loft, JI Silverberg… - Journal of the American …, 2021 - Elsevier
Background Dupilumab, the first biological drug to be approved for the treatment of
moderate to severe atopic dermatitis in adolescents and adults, has shown good efficacy …
被引用次数：208 相关文章

Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis

AS Halling, N Loft, JI Silverberg… - Journal of the American …, 2021 - jaad.org
Background Dupilumab, the first biological drug to be approved for the treatment of
moderate to severe atopic dermatitis in adolescents and adults, has shown good efficacy …

[引用][C] Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis.

AS Halling, N Loft, JI Silverberg… - Journal of the …, 2020 - hsrc.himmelfarb.gwu.edu
"Real-world evidence of dupilumab efficacy and risk of adverse events: " by Anne-Sofie Halling,
Nikolai Loft et al. Home Search Browse Collections My Account About DC Network Digital …

Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis

AS Halling, N Loft, JI Silverberg… - Journal of the …, 2021 - research.regionh.dk
BACKGROUND: Dupilumab, the first biological drug to be approved for the treatment of
moderate to severe atopic dermatitis in adolescents and adults, has shown good efficacy …

Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis

AS Halling, N Loft, JI Silverberg… - Journal of the …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Dupilumab, the first biological drug to be approved for the treatment of
moderate to severe atopic dermatitis in adolescents and adults, has shown good efficacy …

[引用][C] Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis

AS Halling, N Loft, JI Silverberg… - Journal of the American …, 2021 - cir.nii.ac.jp
Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and
meta-analysis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis.

AS Halling, N Loft, JI Silverberg… - Journal of the …, 2020 - europepmc.org
Background Dupilumab, the first biological drug to be approved for the treatment of
moderate to severe atopic dermatitis in adolescents and adults, has shown good efficacy …